ARCHIVES

Biomedical Panel To Hear Public At Sept. Meeting

This article is from The Cancer Letter archive.

Vol. 01 No. 28 | July 11, 1975

Download PDF Visit The Full Archive

Related Articles

ImClone Offered C225 Deal To Seven Firms Prior To BMS

February 22, 2002

In Brief: Norman Sharpless Named Director of UNC Lineberger

September 6, 2013

Rosenberg Team May Have Cloned Melanoma Gene

May 31, 1991

Hydridoma Cell Lines Available

March 5, 1982

DRCCA Board Cool On communications Network, Hears Report On Behavior Program

May 21, 1982

NCI Advisors Criticize a Biomarker Study Touted as High Priority for NCI and FDA.

July 13, 2007